FDA Inspection 732653 — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC — FEI 3001833549

The FDA completed an inspection of Fresenius Kabi USA, LLC on July 8, 2011 in Grand Island, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 8, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grand Island, NY (United States)